MicroStrategy
MSTR
Tesla
TSLA
MARA Holdings
MARA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
GLYC GlycoMimetics
- 0.2420
- +0.0255+11.78%
Close Dec 24 13:00 ET
- 0.2382
- -0.0038-1.57%
Post 16:24 ET
15.61MMarket Cap-0.39P/E (TTM)
0.2424High0.2050Low406.71KVolume0.2050Open0.2165Pre Close93.34KTurnover0.95%Turnover RatioLossP/E (Static)64.48MShares3.529952wk High1.38P/B10.36MFloat Cap0.140652wk Low--Dividend TTM42.82MShs Float26.0500Historical High--Div YieldTTM17.28%Amplitude0.1406Historical Low0.2290Avg Price1Lot Size
About GlycoMimetics Company
GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.
Company Profile
SymbolGLYC
Company NameGlycoMimetics
Listing DateJan 10, 2014
Issue Price8.00
Founded2003
CEOMr. Harout Semerjian
MarketNASDAQ
Employees35
Fiscal Year Ends12-31
Address9708 Medical Center Drive
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-240-243-1201
Websitehttp://www.glycomimetics.com
Company Executives
- Name
- Position
- Salary
- Harout Semerjian
- Director, President and Chief Executive Officer
- 2.39M
- Chinmaya Rath
- Chief Business Officer and Senior Vice President
- --
- Bruce S. Johnson
- Chief Commercial Officer and Senior Vice President
- --
- Brian M. Hahn
- Principal Accounting Officer, Chief Financial Officer and Senior Vice President
- 1.30M
- Timothy R. Pearson
- Chairman of the Board
- 138.00K
- Rachel K. King
- Director
- 96.00K
- Dr. Mark Alan Goldberg, M.D.
- Independent Director
- 111.00K
- Patricia S. Andrews
- Independent Director
- 105.00K
- Daniel M. Junius
- Independent Director
- 118.50K
- Scott T. Jackson, M.B.A.
- Independent Director
- 111.00K
- Dr. Scott Koenig, M.D.,PhD
- Independent Director
- 100.50K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
